Stockscreener 앱 받기
7.85
20.06%
-1.97
전일 마감가:
$9.82
열려 있는:
$8.55
하루 거래량:
106.67K
Relative Volume:
4.15
시가총액:
$1.39M
수익:
-
순이익/손실:
$-20.70M
주가수익비율:
-0.0294
EPS:
-266.6267
순현금흐름:
$-15.13M
1주 성능:
-35.48%
1개월 성능:
-54.68%
6개월 성능:
-94.34%
1년 성능:
-99.66%
1일 변동 폭
$7.45
$11.00
1주일 범위
$7.45
$12.99
52주 변동 폭
$7.45
$4,200.00
Cdt Equity Inc Stock (CDT) Company Profile
명칭
Cdt Equity Inc
전화
(646) 491 9132
주소
4851 TAMIAMI TRAIL NORTH, NAPLES
Compare CDT vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CDT
Cdt Equity Inc
|
7.85 | 1.39M | 0 | -20.70M | -15.13M | -266.63 |
VRTX
Vertex Pharmaceuticals Inc
|
433.07 | 110.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
737.71 | 77.99B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
691.40 | 42.91B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
317.36 | 42.09B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
283.03 | 31.42B | 5.36B | 287.73M | 924.18M | 2.5229 |
Cdt Equity Inc 주식(CDT)의 최신 뉴스
CDT Crashes 24% in Intraday Trading Amid Patent Filing and Market Doldrums — What’s Next? - Bitget
CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings - Bitget
CDT Equity files patents for tapinarof combination therapy - Investing.com
CDT Equity files patents for tapinarof combination therapy By Investing.com - Investing.com India
Psoriasis drug tapinarof gets 2 new patent filings as CDT targets licensing - Stock Titan
CDT Equity approves 1-for-25 reverse stock split effective Thursday - Investing.com India
Conduit to change name to CDT Equity - MSN
Cdt Equity Inc. announces reverse stock split - marketscreener.com
CDT Equity announces reverse stock split - MSN
CDT Equity Announces 1-for-25 Reverse Stock Split - tipranks.com
Reverse split shrinks CDT Equity (NASDAQ: CDT) share count 25-to-1 - Stock Titan
CDT Equity Inc. Announces Reverse Stock Split - bitget.com
CDT shrinks share count to about 4.7M in 1-for-25 reverse split - Stock Titan
Cdt identifies rare disease opportunities through Sarborg Signature Analysis, advancing out-licensing strategy - marketscreener.com
CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy - The Manila Times
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
If You Invested $1,000 in CDT Equity (CDT) - Stock Titan
CDT Equity Inc. 8-K Filing March 17, 2026: Company Details, Address, Trading Symbol, and Emerging Growth Status - Minichart
CDT Equity Shareholders Approve Major Capital Restructuring Measures - TipRanks
CDT Equity (NASDAQ: CDT) wins backing for large share issues and Cayman move - Stock Titan
Latest CDT NewsConduit Pharmaceuticals to Present at the Op... - Stock Titan
CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth - Bitget
Cdt Equity stockholders approve all proposals at special meeting, positioning the company for next phase of growth - marketscreener.com
Cdt Equity Stockholders Approve All Proposals At Special Meeting, Positioning The Company For Next Phase Of Growth - TradingView
CDT Equity to map asset portfolio against rare disease database By Investing.com - Investing.com India
CDT Equity to map asset portfolio against rare disease database - Investing.com South Africa
CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence - The Manila Times
CDT Stock Price, Quote & Chart | CDT EQUITY INC (NASDAQ:CDT) - ChartMill
CDT Equity Expands Financing Through New Convertible Note - The Globe and Mail
Cdt Equity lowers floor price to $0.60 in purchase agreement amendment on March 3, 2026SEC filing - marketscreener.com
CDT Equity Lowers Floor Price To $0.60 In Purchase Agreement Amendment On March 3, 2026SEC Filing - TradingView
CDT Equity (CDT) lowers ELOC floor and issues $555,556 secured convertible note - Stock Titan
CDT Equity notes Sarborg patent filing for AI technology By Investing.com - Investing.com Canada
CDT Equity notes Sarborg patent filing for AI technology - Investing.com
CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent - Bitget
CDT Positions for Transformational Growth - Bitget
AI and drug assets: CDT puts $115M into Sarborg to fuel growth - Stock Titan
CDT Equity Inc. announced that it has received $0.555556 million in funding - marketscreener.com
CDT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Short Interest in CDT Equity Inc. (NASDAQ:CDT) Declines By 73.3% - Defense World
CDTTW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Conduit Pharmaceuticals Expands Stake Using Equity-Funded Acquisition Strategy - The Globe and Mail
CDT Equity to Acquire 20% of Sarborg in Stock, Pre-Funded Warrants and $8 Million Cash - TradingView
CDT Equity (NASDAQ: CDT) uses shares and warrants to acquire 20% of Sarborg - Stock Titan
CDT Equity Inc. Acknowledges Sarborg Limited's Expansion of AI Signature Agent Platform into Bacteria and Agrochemicals - Quiver Quantitative
CDT Equity Notes Sarborg Expansion into Bacteria and Agrochemicals - Bitget
Cdt Equity Inc (CDT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.03%
2.20%
자본화:
|
볼륨(24시간):